Irbesartan and hydrochlorothiazide tablets, indicated for the treatment of hypertension, are the generic version of Sanofi Aventis’s Avalide tablets.
Currently, Mylan has 92 abbreviated new drug applications pending FDA approval, 20 of which are potential first-to-file opportunities.